Combining COVID-19 and HIV testing could help reduce the spread of both viruses

  • A computer model suggests the COVID-19 pandemic could facilitate the spread of HIV
  • Disruptions to healthcare services would drive a 9% increase in new HIV infections
  • However, integrating HIV and COVID-19 testing could reduce new HIV infections 17%

The global COVID-19 pandemic has burdened health systems and disrupted routine medical care for many people. It is at least plausible that this disruption caused by the pandemic may create conditions that facilitate the spread of HIV, as people may be unable to access services such as PrEP (pre-exposure prophylaxis) prescriptions and testing for HIV and other sexually transmitted infections (STIs).

The pandemic along with its associated changes-self-isolation, physical distancing, psychological distress-has been reported to reduce access to syringe services programs, opioid substitution therapy and social services, among others. All of these changes could make it more difficult to reach vulnerable populations, thus facilitating the spread of HIV and other infections.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search